Bill Snyder Archive — Page 38 of 119
-
October 14, 2021
New marker for metaplasia
A protein that transports water, called aquaporin 5, is expressed by cells undergoing changes that may increase risk for gastric cancer development, Vanderbilt researchers discovered. -
October 14, 2021
STAR Clinical Research Network to receive major grant renewal
Vanderbilt's STAR Clinical Research Network has been approved for an additional $8.9 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) to support its efforts to improve health care throughout the Southeast and across the United States. -
October 7, 2021
Study seeks to improve kidney transplant outcomes among Black patients
-
October 7, 2021
Nominations sought for VUSM Research Staff Awards
-
October 5, 2021
AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC
Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19. -
October 1, 2021
VUMC research contributed to first COVID-19 pill now under review
Vanderbilt research helped allow pharmaceutical giant Merck & Co. to authorization for the first oral antiviral pill to treat COVID-19.